DongKoo Bio & Pharma Co. Ltd. Market Cap ($21.80 Million)
Market Cap & Net Worth: DongKoo Bio & Pharma Co. Ltd. (006620)
DongKoo Bio & Pharma Co. Ltd. market cap. DongKoo Bio & Pharma Co. Ltd. (KQ:006620) has a market capitalization of $21.80 Million (₩32.17 Billion) as of November 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #24662 globally and #1779 in its home market, demonstrating a 3.72% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying DongKoo Bio & Pharma Co. Ltd.'s stock price ₩3350.00 by its total outstanding shares 9604000 (9.60 Million). Also see DongKoo Bio & Pharma Co. Ltd. cash flow conversion for how efficiently the company converts equity into cash flow.
DongKoo Bio & Pharma Co. Ltd. Market Cap History (2018–2026)
DongKoo Bio & Pharma Co. Ltd. market cap history from 2018 to 2026. Data shows change from $39.38 Million to $21.80 Million (-13.68% CAGR). Check today's stock price for DongKoo Bio & Pharma Co. Ltd. for real-time trading data and today's change.
Index Memberships
DongKoo Bio & Pharma Co. Ltd. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$203.83 Billion | 0.01% | #929 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$203.83 Billion | 0.01% | #929 of 1384 |
Weight: DongKoo Bio & Pharma Co. Ltd.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
DongKoo Bio & Pharma Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how DongKoo Bio & Pharma Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 006620 net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
DongKoo Bio & Pharma Co. Ltd.'s market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
DongKoo Bio & Pharma Co. Ltd.'s market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $39.38 Million | $104.84 Billion | $4.57 Billion | 0.00x | 0.01x |
| 2019 | $34.48 Million | $125.24 Billion | $15.10 Billion | 0.00x | 0.00x |
| 2020 | $51.62 Million | $139.22 Billion | $9.14 Billion | 0.00x | 0.01x |
| 2021 | $51.46 Million | $155.15 Billion | $9.33 Billion | 0.00x | 0.01x |
| 2022 | $39.11 Million | $194.99 Billion | $6.61 Billion | 0.00x | 0.01x |
| 2023 | $36.84 Million | $215.69 Billion | $11.81 Billion | 0.00x | 0.00x |
| 2024 | $31.24 Million | $249.27 Billion | $2.04 Billion | 0.00x | 0.02x |
| 2025 | $35.60 Million | $242.69 Billion | $50.27 Billion | 0.00x | 0.00x |
Competitor Companies of 006620 by Market Capitalization
Companies near DongKoo Bio & Pharma Co. Ltd. in the global market cap rankings as of November 4, 2026. Also see 006620 total asset value for a full breakdown of the balance sheet.
Key companies related to DongKoo Bio & Pharma Co. Ltd. by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #5272 globally with a market cap of $2.49 Billion USD ( ₩3.67 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #8989 globally with a market cap of $902.70 Million USD ( ₩1.33 Trillion KRW).
- NatureCell Co.Ltd (KQ:007390): Ranked #9557 globally with a market cap of $793.12 Million USD ( ₩1.17 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #10371 globally with a market cap of $674.16 Million USD ( ₩994.80 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #5272 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $2.49 Billion | ₩171400.00 |
| #8989 | ST Pharm Co.Ltd | KQ:237690 | $902.70 Million | ₩71400.00 |
| #9557 | NatureCell Co.Ltd | KQ:007390 | $793.12 Million | ₩22050.00 |
| #10371 | Oscotec Inc | KQ:039200 | $674.16 Million | ₩35400.00 |
Market Capitalization of DongKoo Bio & Pharma Co. Ltd. (2018–2026)
Market capitalization of DongKoo Bio & Pharma Co. Ltd. from 2018 to today. Between 2018 and today, DongKoo Bio & Pharma Co. Ltd.'s market cap moved from $39.38 Million to $ 21.80 Million, with a yearly change of -13.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩21.80 Million | -38.76% |
| 2025 | ₩35.60 Million | +13.96% |
| 2024 | ₩31.24 Million | -15.19% |
| 2023 | ₩36.84 Million | -5.82% |
| 2022 | ₩39.11 Million | -23.99% |
| 2021 | ₩51.46 Million | -0.31% |
| 2020 | ₩51.62 Million | +49.72% |
| 2019 | ₩34.48 Million | -12.44% |
| 2018 | ₩39.38 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of DongKoo Bio & Pharma Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $21.80 Million USD |
| MoneyControl | $21.80 Million USD |
| MarketWatch | $21.80 Million USD |
| marketcap.company | $21.80 Million USD |
| Reuters | $21.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About DongKoo Bio & Pharma Co. Ltd.
DongKoo Bio&Pharma. Co., Ltd. researches, develops, manufactures, and sells medicines in South Korea. The company offers prescribed medicines, such as liver disease, skeletal muscle relaxant, endocrine system, brain nervous system, urogenital, antiobestic, digestive system, circulatory organ, allergenic, mental disease, oral dermatology, external preparation of dermatology, antiseptic, antiviral,… Read more